The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treatment, and the entry of new foreign and domestic competitors.

This Medtech 360 Report provides high-level market metrics for interventional oncology devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Table of contents

  • Asia Pacific (Supplemental)
    • Abstract
    • Version History
    • Interventional Oncology Device Market
      • Market Definitions
        • Geographies Covered
        • Procedures Covered
        • Products Covered
      • Market Forecast Data
    • Ablation Device Market
      • Market Definitions
      • Market Forecast Data
    • Embolization Particle Market
      • Market Definitions
      • Market Forecast Data
    • Appendix
      • Abbreviations

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is a senior analyst within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali. Follow Bishwjit on twitter: @Bishwjit_DRG


Related Reports

Interventional Oncology Devices | Medtech 360 | Market Insights | Japan

Despite short-term contraction caused by the ongoing COVID-19 pandemic, as well as delays in the availability of new technologies due to strict regu...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific

Despite the challenges posed by the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe

European interventional oncology device procedure volumes and revenues will grow moderately, driven by an expanding patient population, rising patient and physician awareness, improved reimburse...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Latin America

The Latin American interventional oncology device market will see moderate growth, driven by an increasing patient population, adoption of premium-priced devices, and the introduction of new dev...

View Details